Analyst firms · Citigroup · ARVN

Citigroup ARVN price target and rating history

Arvinas Inc. (ARVN) · Health Care

Citigroup rates Arvinas Inc. (ARVN) Buy with a $15 price target, as of its latest action on Jan 6, 2026. It has published 3 rating actions on ARVN since July 2021, including 1 upgrade and 1 downgrade.

Current rating
Buy
Price target
$15
Median target, all firms
Too few
Actions on ARVN
3

Citigroup price target on ARVN

$153$84$1520222023202420252026
Citigroup price target on ARVN, each point a stated target, July 2021 to January 2026.

Every Citigroup rating on ARVN

How other firms rate ARVN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Wells FargoEqual WeightAug 4, 2026
CitigroupBuy$15Jan 6, 2026

Questions about Citigroup and ARVN

What is Citigroup's price target for ARVN?
Citigroup's latest stated price target for Arvinas Inc. (ARVN) is $15, from its action on Jan 6, 2026.
What is Citigroup's rating on ARVN?
Citigroup rates ARVN Buy, a bullish rating, as of Jan 6, 2026.
When did Citigroup last change its view on ARVN?
On Jan 6, 2026, Citigroup upgrades to Buy from Neutral, price target $15.

More ARVN rating histories

All Citigroup ratingsARVN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.